$CRBP: Analyst: This Pharma Stock Could Triple

Date: Friday, December 7th, 2018

Stock(s) mentioned:

Source: Schaeffers Research (https://www.schaeffersresearch.com)

Summary: RBC initiated coverage on Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) with an “outperform” rating and $23 price target — a 245% premium to last …

Full article address: https://www.schaeffersresearch.com/content/news/2018/12/07/analyst-this-pharma-stock-could-triple

Related News:

$GWPH $CRBP: Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals

$CRBP: Corbus Pharmaceuticals Holdings, Inc (CRBP) CEO Yuval Cohen …

$CRBP: Why Corbus Pharmaceuticals Holdings Inc. Tumbled Today

$CGC $CRBP $NBEV: Why Canopy Growth, Corbus Pharmaceuticals Holdings, and New …

$CRBP: Corbus stock jumps after biotech purchases hundreds of potential …

$CRBP: Why Corbus Pharmaceuticals Holdings Is Flying High Today

$CRBP: Corbus Pharmaceuticals licenses worldwide rights for more than …

$CRBP: Corbus Pharmaceuticals Expands Target Indications by Adding …

Latest News:

$GOOG $AAPL: Your apps are tracking you — here’s how to stop them

$SPX: Here’s what smart rich people really do with their nest egg

$SPX: How the rich get richer in every type of stock market

$VSLR $RUN: Solar Stocks Are Finally Seeing a Brighter Future

$IAG: Is IAMGOLD Corporation a Buy?

$TWTR: 3 Ways Twitter Is Driving Ad Revenue Growth

$TME $LEGH: US IPO Weekly Recap: 2018 Wraps Up With Tencent Music

$KMLGF $KMI: Where Will Kinder Morgan Canada Be in 1 Year?

$EVA: 3 Top Stocks With High Dividend Yields

$BABA: Box Lacrosse Set to Return to Long Island. Will It Stick This Time?

$0700.HK $ATVI $DIS $TTWO: The ‘Fortnite’ Dance Move That Spawned a Lawsuit